Glutamate Excitotoxicity Is Involved in the Induction of Paralysis in Mice after Infection by a Human Coronavirus with a Single Point Mutation in Its Spike Protein
- 1 December 2011
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (23), 12464-12473
- https://doi.org/10.1128/jvi.05576-11
Abstract
Human coronaviruses (HCoV) are recognized respiratory pathogens, and some strains, including HCoV-OC43, can infect human neuronal and glial cells of the central nervous system (CNS) and activate neuroinflammatory mechanisms. Moreover, HCoV-OC43 is neuroinvasive, neurotropic, and neurovirulent in susceptible mice, where it induces chronic encephalitis. Herein, we show that a single point mutation in the viral spike (S) glycoprotein (Y241H), acquired during viral persistence in human neural cells, led to a hind-limb paralytic disease in infected mice. Inhibition of glutamate excitotoxicity using a 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propranoic acid (AMPA) receptor antagonist (GYKI-52466) improved clinical scores related to the paralysis and motor disabilities in S mutant virus-infected mice, as well as protected the CNS from neuronal dysfunctions, as illustrated by restoration of the phosphorylation state of neurofilaments. Expression of the glial glutamate transporter GLT-1, responsible for glutamate homeostasis, was downregulated following infection, and GYKI-52466 also significantly restored its steady-state expression level. Finally, GYKI-52466 treatment of S mutant virus-infected mice led to reduced microglial activation, which may lead to improvement in the regulation of CNS glutamate homeostasis. Taken together, our results strongly suggest an involvement of excitotoxicity in the paralysis-associated neuropathology induced by an HCoV-OC43 mutant which harbors a single point mutation in its spike protein that is acquired upon persistent virus infection.Keywords
This publication has 59 references indexed in Scilit:
- Pharmacological preconditioning with GYKI 52466: a prophylactic approach to neuroprotectionFrontiers in Neuroscience, 2010
- Disrupted Glutamate Transporter Expression in the Spinal Cord With Acute Flaccid Paralysis Caused by West Nile Virus InfectionJournal of Neuropathology and Experimental Neurology, 2009
- Tumor necrosis factor-α modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitisBrain Research, 2009
- In vitro glutaminase regulation and mechanisms of glutamate generation in HIV‐1‐infected macrophageJournal of Neurochemistry, 2009
- Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infectionProceedings of the National Academy of Sciences of the United States of America, 2008
- The inflammatory cytokine, interleukin‐1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitisJournal of Neurochemistry, 2008
- HIV‐infected macrophages mediate neuronal apoptosis through mitochondrial glutaminaseJournal of Neurochemistry, 2007
- Neuroinflammation and regulation of glial glutamate uptake in neurological disordersJournal of Neuroscience Research, 2007
- Glutamate release from activated microglia requires the oxidative burst and lipid peroxidationJournal of Neurochemistry, 2007
- Neurofilaments in health and diseaseMedical Molecular Morphology, 2000